Lifeway: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Nov. 12, 2026, Lifeway (NASDAQ:LWAY) announced record quarterly net sales of $67.8 million. The maker of kefir, a fermented milk drink rich in probiotics, is managing high customer demand alongside factory bottlenecks and input cost inflation. Three key takeaways stand out for long-term investors.

1. Factory Expansion Project Will Double Production Capacity in 2027

High customer demand forced management to put existing accounts on allocation, restricting orders as factory output reached its physical ceiling. Expanding the Waukesha, Wisconsin facility will double bottling capacity and clear customer backlogs starting in early 2027.

At completion, the project will more than double the facility's capacity, modernize our operations and improve efficiency. It is a worthy and necessary investment as we tackle the next stage of our growth.
-- Julie Smolyansky, President and Chief Executive Officer

2. Price Increases and Operational Efficiency Target Historic Gross Margins

Milk prices remained elevated after a 26% surge from Q1 to Q2, pushing third-quarter gross margin down to 18%. Management is implementing rolling price increases across retail partners to rebuild profit margins toward historical levels above 25%.

And with our operational efficiencies out of Waukesha, we'll have the perfect storm, and we believe we can rebound to our historic margins of 25% plus.
-- Julie Smolyansky, President and Chief Executive Officer

3. Health Trends and GLP-1 Adoption Drive Retail Shelf Expansion

Consumer interest in gut health, high-protein diets, and GLP-1 weight-loss medication regimens creates tailwinds for drinkable fermented dairy. Retail partners are allocating more shelf space as Lifeway expands placement in national grocery chains.

A growing population of GLP-1 users are looking for nutrient-dense, probiotic-rich foods that support satiation and digestive health.
-- Julie Smolyansky, President and Chief Executive Officer

Looking Ahead

Consumer demand for probiotic dairy items remains high, though production constraints and milk cost inflation create short-term friction. Lifeway relies on its brand recognition, established grocery relationships, and low debt to protect its market lead while management tracks commodity cost stabilization and price realization.

We will continue to add shifts and supplement production with co-manufacturing partners, but we foresee a major opportunity to capitalize on unmet demand in 2027.
-- Julie Smolyansky, President and Chief Executive Officer

The company's focus remains on converting current brand momentum into multi-year market share gains across retail channels.

We delivered the highest quarterly net sales in the company's history, extended our growth streak to 28 consecutive quarters, and were recognized by Fortune as one of America's fastest-growing companies.
-- Julie Smolyansky, President and Chief Executive Officer

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.